{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:05:44Z","timestamp":1784196344065,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05021-7","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:04:44Z","timestamp":1769414684000},"page":"2917-2927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of frailty status and histopathological features on upstaging of non-muscle-invasive bladder cancer: a critical analysis based on machine learning"],"prefix":"10.1007","volume":"58","author":[{"given":"Sami Berk","family":"\u00d6zden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"\u0130lki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admir","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cetin","family":"Demirdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinharib","family":"Citgez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"3","key":"5021_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5021_CR2","first-page":"36","volume":"83","author":"M Babjuk","year":"2023","unstructured":"Babjuk M, Burger M, Comp\u00e9rat EM, Gontero P, Mostafid AH, Palou J et al (2023) EAU guidelines on non-muscle-invasive bladder cancer (Ta, T1, and CIS). Eur Urol 83(1):36\u201359","journal-title":"Eur Urol"},{"issue":"6","key":"5021_CR3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/JU.0000000000002213","volume":"206","author":"SS Chang","year":"2021","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR et al (2021) Diagnosis and treatment of non-muscle-invasive bladder cancer: AUA\/SUO Guideline. J Urol 206(6):1114\u20131122","journal-title":"J Urol"},{"issue":"3","key":"5021_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in Ta-T1 bladder cancer using EORTC risk tables. Eur Urol 49(3):466\u2013477","journal-title":"Eur Urol"},{"issue":"5","key":"5021_CR5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M et al (2009) The CUETO scoring model. J Urol 182(5):2195\u20132203","journal-title":"J Urol"},{"issue":"9","key":"5021_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/cancers16091684","volume":"16","author":"A \u015alusarczyk","year":"2024","unstructured":"\u015alusarczyk A, Szyma\u0144ski \u0141, Wr\u00f3bel A, Ko\u0142odziej A, Ch\u0142osta PL (2024) External validation of NMIBC risk groups. Cancers (Basel) 16(9):1684","journal-title":"Cancers (Basel)"},{"key":"5021_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41746-024-01088-7","volume":"7","author":"E Kwong","year":"2024","unstructured":"Kwong E, Li M, Hong MKH (2024) Artificial intelligence applications in non-muscle-invasive bladder cancer: a systematic review. NPJ Digit Med 7:150","journal-title":"NPJ Digit Med"},{"issue":"11","key":"5021_CR8","volume":"36","author":"N Tokuyama","year":"2023","unstructured":"Tokuyama N, Takahashi S, Ikeda J, Osakabe M, Fujimoto A, Tsuboi M et al (2023) Deep learning\u2013based analysis of bladder tumor histopathology for recurrence prediction. Mod Pathol 36(11):100176","journal-title":"Mod Pathol"},{"key":"5021_CR9","first-page":"66870","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Zhou L, Liu X, Zhang J, Chen J, He L et al (2024) Deep learning pathomics model predicts recurrence in NMIBC. Sci Rep 14:66870","journal-title":"Sci Rep"},{"issue":"3","key":"5021_CR10","first-page":"345","volume":"132","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Park Y, Moon KC, Cho NH, Kwon GY et al (2023) Machine learning-based prediction of progression in non-muscle-invasive bladder cancer. BJU Int 132(3):345\u2013353","journal-title":"BJU Int"},{"issue":"4","key":"5021_CR11","first-page":"545","volume":"485","author":"EJ Van Limbergen","year":"2024","unstructured":"Van Limbergen EJ, Lerut E, Mangel L et al (2024) Artificial intelligence and deep learning in bladder cancer pathology: current status and future perspectives. Virchows Arch 485(4):545\u2013556","journal-title":"Virchows Arch"},{"issue":"3","key":"5021_CR12","first-page":"122","volume":"42","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhu Z, Wang J et al (2024) Challenges and opportunities for AI in NMIBC prognostication. Urol Oncol 42(3):122\u2013131","journal-title":"Urol Oncol"},{"issue":"4","key":"5021_CR13","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/j.clgc.2023.03.004","volume":"21","author":"N Pyrgidis","year":"2023","unstructured":"Pyrgidis N, Sokolakis I, Haltmair G, Hatzichristodoulou G (2023) The short- and long-term effect of radical cystectomy in frail patients with bladder cancer. Clin Genitourin Cancer 21(4):e291\u2013e298. https:\/\/doi.org\/10.1016\/j.clgc.2023.03.004","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"5021_CR14","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/j.clgc.2021.12.016","volume":"20","author":"S Yamashita","year":"2022","unstructured":"Yamashita S, Mashima N, Higuchi M et al (2022) Modified 5-item frailty index score as prognostic marker after radical cystectomy in bladder cancer. Clin Genitourin Cancer 20(3):e210\u2013e216. https:\/\/doi.org\/10.1016\/j.clgc.2021.12.016","journal-title":"Clin Genitourin Cancer"},{"key":"5021_CR15","unstructured":"P. Gontero, A. Birtle, E. Comp\u00e9rat, et al. Non-Muscle Invasive Bladder Cancer(TaT1 and CIS). 2025, EAU Guidelines Office, Arnhem, The Netherlands, ISBN 978\u201394\u201392671\u201329\u20135"},{"key":"5021_CR16","unstructured":"Van der Heijden AG, Bruins HM, Carrion A, et al. Muscle-invasive and Metastatic Bladder Cancer. 2025, EAU Guidelines Office, Arnhem, The Netherlands, ISBN 978\u201394\u201392671\u201329\u20135"},{"issue":"7","key":"5021_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00420-013-0916-3","volume":"87","author":"B Pesch","year":"2014","unstructured":"Pesch B, Taeger D, Johnen G et al (2014) Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines. Int Arch Occup Environ Health 87(7):715\u2013724. https:\/\/doi.org\/10.1007\/s00420-013-0916-3","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"5021_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"issue":"11","key":"5021_CR19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/dc12-0336","volume":"35","author":"K Esposito","year":"2012","unstructured":"Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer. Diabetes Care 35(11):2402\u20132411. https:\/\/doi.org\/10.2337\/dc12-0336","journal-title":"Diabetes Care"},{"issue":"4","key":"5021_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/annonc\/mdr347","volume":"23","author":"J Stebbing","year":"2012","unstructured":"Stebbing J, Sharma A, North B et al (2012) A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy. Ann Oncol 23(4):860\u2013866. https:\/\/doi.org\/10.1093\/annonc\/mdr347","journal-title":"Ann Oncol"},{"key":"5021_CR21","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classificaton of tumours series, 5th ed.; vol. 8) https:\/\/publications.iarc.fr\/610."},{"issue":"8","key":"5021_CR22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.urolonc.2014.05.009","volume":"32","author":"S Rausch","year":"2014","unstructured":"Rausch S, Hennenlotter J, Todenh\u00f6fer T et al (2014) Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression--introducing a novel prognostic model for bladder cancer recurrence. Urol Oncol 32(8):1178\u20131183. https:\/\/doi.org\/10.1016\/j.urolonc.2014.05.009","journal-title":"Urol Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05021-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05021-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05021-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:19:01Z","timestamp":1784193541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05021-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5021"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05021-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Istanbul University-Cerrahpa\u015fa, Cerrahpa\u015fa Faculty of Medicine Ethics Committee (Date: 18.06.2025, No: E-74555795-050.04-1337608) and conducted in accordance with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all participants for urodynamic testing, cystoscopy, and bladder biopsy as part of standard clinical care. The ethics committee waived the requirement for additional informed consent for the retrospective analysis of anonymized patient data. Patient confidentiality was strictly maintained.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as the manuscript does not contain identifiable personal data, images, or details of individual participants.","order":3,"name":"Ethics","label":"Consent for study and publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}